A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples

作者：Usuki Seigo; O'Brien Dawn; Rivner Michael H; Yu Robert K^*

来源：Journal of Immunological Methods, 2014, 408: 52-63.

DOI：10.1016/j.jim.2014.05.005

• Anti-glycolipid antibody
• GBS
• ALS
• CIDP
• ELISA
• Non-specific adhesions

The enzyme-linked immunosorbent assay (ELISA) is a standard immunoassay used in measuring antibody reactivity (expressed as titers) for glycosphingolipids (GSLs) such as gangliosides and sulfoglycolipids in the sera of patients with Guillain Barre syndrome (GBS), variants of GBS, and chronic inflammatory demyelinating polyneuropathy (CIDP). In the present study, anti-GSL antibodies were evaluated using a new formula of affinity parametric complex (APC), calculated from limiting-dilution serum assay data, followed by affinity parametric complex criterion (APCC). Using assay results based on APCC, we analyzed serum samples categorized into acute inflammatory demyelinating polyneuropathy (AIDP), acute motor-sensory axonal neuropathy (AMSAN), CIDP, CIDP with myasthenia gravis (MG), and Amyotrophic Lateral Sclerosis (ALS). We were able to determine the affinity strength of antibodies otherwise hidden in the non-specific background activity in highly adhesive serum samples. The thin-layer chromatography (TLC)-immuno-overlay method assured us that this new method is an accurate and reliable way for evaluating anti-GSL antibodies using ELISA serum sample data. Published by Elsevier B.V.

• 出版日期2014-6